Risk stratification of patients with acute symptomatic pulmonary embolism
Authors:
- 14 January 2016
- journal article
- review article
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 11 (1) , 11-18
Abstract
Patients with acute symptomatic pulmonary embolism (PE) who present with arterial hypotension or shock have a high risk of death (high-risk PE), and treatment guidelines recommend strong consideration of thrombolysis in this setting. For normotensive patients diagnosed with PE, risk stratification should aim to differentiate the group of patients deemed as having a low risk for early complications (all-cause mortality, recurrent venous thromboembolism, and major bleeding) (low-risk PE) from the group of patients at higher risk for PE-related complications (intermediate-high risk PE), so low-risk patients could undergo consideration of early outpatient treatment of PE and intermediate-high risk patients would undergo close observation and consideration of thrombolysis. Clinicians should also use risk stratification and eligibility criteria to identify a third group of patients that should not undergo escalated or home therapy (intermediate-low risk PE). Such patients should initiate standard therapy of PE while in the hospital. Clinical models [e.g., Pulmonary Embolism Severity Index (PESI), simplified PESI (sPESI)] may accurately identify those at low risk of dying shortly after the diagnosis of PE. For identification of intermediate-high risk patients with acute PE, studies have validated predictive models that use a combination of clinical, laboratory and imaging variables.Keywords
Funding Information
- ISCIII (FIS 2011 [PI11/00246])
This publication has 45 references indexed in Scilit:
- Computed tomography‐assessed right ventricular dysfunction and risk stratification of patients with acute non‐massive pulmonary embolism: systematic review and meta‐analysisJournal of Thrombosis and Haemostasis, 2013
- Echocardiography and pulmonary embolism severity index have independent prognostic roles in pulmonary embolismEuropean Respiratory Journal, 2012
- Antithrombotic Therapy for VTE DiseaseChest, 2012
- The effects of cause of death classification on prognostic assessment of patients with pulmonary embolismJournal of Thrombosis and Haemostasis, 2011
- Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolismThorax, 2010
- Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolismEuropean Heart Journal, 2010
- Elevated Heart-Type Fatty Acid-Binding Protein Levels on Admission Predict an Adverse Outcome in Normotensive Patients With Acute Pulmonary EmbolismJACC, 2010
- Prognostic Significance of Troponin Elevation and Right Ventricular Enlargement in Acute Pulmonary EmbolismThe American Journal of Cardiology, 2005
- The Epidemiology of Venous ThromboembolismCirculation, 2003
- Echocardiography Doppler in pulmonary embolism: Right ventricular dysfunction as a predictor of mortality rateAmerican Heart Journal, 1997